GP-Act III Acquisition Corp. Class A Ordinary Share (NASDAQ:GPAT) — Market Cap & Net Worth
Market Cap & Net Worth: GP-Act III Acquisition Corp. Class A Ordinary Share (GPAT)
GP-Act III Acquisition Corp. Class A Ordinary Share (NASDAQ:GPAT) has a market capitalization of $395.67 Million ($395.67 Million) as of July 22, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #13232 globally and #3248 in its home market, demonstrating a -0.90% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GP-Act III Acquisition Corp. Class A Ordinary Share's stock price $11.01 by its total outstanding shares 35937500 (35.94 Million). Review how much free cash does GP-Act III Acquisition Corp. Class A Ord generate to assess how much free cash flow the company generates relative to operating cash flow.
GP-Act III Acquisition Corp. Class A Ordinary Share Market Cap History: 2024 to 2026
GP-Act III Acquisition Corp. Class A Ordinary Share's market capitalization history from 2024 to 2026. Data shows growth from $364.41 Million to $395.67 Million (4.86% CAGR).
Index Memberships
GP-Act III Acquisition Corp. Class A Ordinary Share is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$40.65 Trillion | 0.00% | #1320 of 3165 |
Weight: GP-Act III Acquisition Corp. Class A Ordinary Share's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
GP-Act III Acquisition Corp. Class A Ordinary Share Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GP-Act III Acquisition Corp. Class A Ordinary Share's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of GPAT by Market Capitalization
Companies near GP-Act III Acquisition Corp. Class A Ordinary Share in the global market cap rankings as of July 22, 2026.
Key companies related to GP-Act III Acquisition Corp. Class A Ordinary Share by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #6335 globally with a market cap of $1.84 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #10759 globally with a market cap of $642.73 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11192 globally with a market cap of $587.05 Million USD.
- Churchill Capital Corp XI (NASDAQ:CCXI): Ranked #11363 globally with a market cap of $568.14 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #6335 | Twenty One Capital, Inc. | NYSE:XXI | $1.84 Billion | $5.32 |
| #10759 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $642.73 Million | $10.09 |
| #11192 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11363 | Churchill Capital Corp XI | NASDAQ:CCXI | $568.14 Million | $14.39 |
GP-Act III Acquisition Corp. Class A Ordinary Share Historical Marketcap From 2024 to 2026
Between 2024 and today, GP-Act III Acquisition Corp. Class A Ordinary Share's market cap moved from $364.41 Million to $ 395.67 Million, with a yearly change of 4.86%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $395.67 Million | +2.99% |
| 2025 | $384.17 Million | +5.42% |
| 2024 | $364.41 Million | -- |
End of Day Market Cap According to Different Sources
On Jul 21st, 2026 the market cap of GP-Act III Acquisition Corp. Class A Ordinary Share was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $395.67 Million USD |
| MoneyControl | $395.67 Million USD |
| MarketWatch | $395.67 Million USD |
| marketcap.company | $395.67 Million USD |
| Reuters | $395.67 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GP-Act III Acquisition Corp. Class A Ordinary Share
GP-Act III Acquisition Corp. does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as GP Investments Acquisition Corp. II and changed its name to GP-Act III Acquisition Corp. in November 2020. GP-Act III Acquisition Corp. … Read more